Medifast, Inc. (MED) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.15 +0.41%
Revenue Growth %: -24.3%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
SICP, MNSB, CFFI, More
Revenue Growth %: -24.3%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q2 EPS of $0.38, $0.09 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $78.3 million versus the consensus estimate of $81.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roper Technologies (ROP) Tops Q3 EPS by 10c ; Offers Guidance
- ACNB Corporation (ACNB) Tops Q3 EPS by 8c
- Tractor Supply (TSCO) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
